Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
基本信息
- 批准号:10173028
- 负责人:
- 金额:$ 16.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-05 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAdaptive Immune SystemAddressAdult Respiratory Distress SyndromeAffectAlcohol consumptionAlcoholic Liver DiseasesAlcoholsAntiviral AgentsAntiviral ResponseCOVID-19COVID-19 pandemicCellsCessation of lifeChronicClinicalCommunicable DiseasesCoronavirusCritical IllnessDataDatabasesDegradation PathwayDiagnosisDiseaseDisease ProgressionDouble-Stranded RNAEpidemicEthanolFailureFrequenciesFutureGeneticGenetic TranscriptionHeavy DrinkingHepatitisHospitalizationIRF3 geneImmuneIndividualLiver diseasesMasksMediatingMedicalMorbidity - disease ratePaperParentsPatientsPeripheralPeripheral Blood Mononuclear CellPrimary Health CareProspective cohort studyPublic HealthRNARNA DegradationRandomizedRegulationResearchResistance to infectionRiskRoleSeveritiesSignal TransductionTest ResultTestingUnited KingdomUpdateViralViral GenesVirus Diseasesadaptive immune responsealcohol exposurealcohol riskbiobankbioinformatics pipelineinfection riskmacrophagemonocytemortalitymouse modelnegative affectpandemic diseasephenotypic dataresponsesingle-cell RNA sequencingtransmission process
项目摘要
ABSTRACT
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2) is a highly contagious and fast-spreading infectious disease, which reached pandemic status in only four
months and is spreading worldwide with millions of people being affected. The clinical spectrum of COVID-19
ranges from mild to critically ill diseases. COVID-19 can progress rapidly into acute respiratory distress syndrome
(ARDS), multiorgan failure, and even death. In the midst of the COVID-19 epidemic, there is some evidence for
increased alcohol purchases. Since people generally buy more alcohol during epidemics, increased alcohol
consumption may result in reduced resistance to infections like COVID-19 and promote the progression of the
disease. SARS-COV-2 is a positive-sense single stranded RNA (ssRNA). While alcohol consumption has not
yet been shown to directly increase risk for SARS-COV-2 transmission or COVID-19 severity, alcohol negatively
affects the both the innate and adaptive immune systems and increases risk for many infectious diseases.
Importantly, recent data from both murine models of ethanol exposure and peripheral blood mononuclear cells
(PBMCs) from patients with alcohol-associated hepatitis (AH) indicate that signaling by viral ss/dsRNA is
disrupted by alcohol, analogous to impact of alcohol on signaling via bacterial products, such as LPS. The parent
RO-1 (Transcriptional and non-transcriptional roles of IRF3 in ALD) for this URGENT COMPETITIVE RENEWAL,
we are investigating the impact of chronic ethanol on ss/ds RNA sensing and activation of IRF3-mediated cellular
responses. Here we propose to extend the scope of this RO1 to address two important aspects of the interaction
of alcohol and COVID-19 in people consuming alcohol. In Specific Aim 1, making use of data from the UK
Biobank, we will ask whether alcohol consumption or alcohol-related diseases increase risk of infection,
hospitalization and mortality. In Specific Aim 2, we will use single cell RNA seq analysis to interrogate the impact
of alcohol consumption on anti-viral responses in peripheral innate and adaptive immune cells. Understanding
the impact of alcohol use on risk for COVID-19 and characterizing the specific cellular changes in anti-viral
responses will meet an important unmet clinical need for guiding public health and medical responses to the
COVID-19 pandemic.
抽象的
冠状病毒病2019(COVID-19)由严重的急性呼吸综合征冠状病毒2(SARS-
COV-2)是一种高度传染性和快速传播的传染病,仅在四个中达到了大流行状态
几个月,在全球范围内传播,数百万的人受到影响。 COVID-19的临床光谱
从轻度到严重的疾病范围。 COVID-19可以迅速发展为急性呼吸窘迫综合征
(ARDS),多器官失败甚至死亡。在Covid-19-19的流行病中,有一些证据表明
增加酒精的购买。由于人们在流行期间通常会购买更多的酒精,因此酒精增加
消费可能会导致对诸如Covid-19之类的感染的抵抗力降低,并促进
疾病。 SARS-COV-2是一个正义的单链RNA(SSRNA)。虽然饮酒尚未
但已证明可以直接增加SARS-COV-2传播或共证的严重程度,酒精造成负面影响的风险
影响先天和适应性免疫系统,并增加许多传染病的风险。
重要的是,来自乙醇暴露和外周血单核细胞的鼠模型的最新数据
(PBMC)来自酒精相关肝炎(AH)的患者表明,病毒SS/DSRNA的信号传导为
被酒精破坏,类似于酒精对通过细菌产物(例如LPS)的信号传导的影响。父母
RO-1(IRF3在ALD中的转录和非转录角色)用于这种紧急竞争续约,
我们正在研究慢性乙醇对SS/DS RNA感应和IRF3介导的细胞激活的影响
回答。在这里,我们建议扩展此RO1的范围,以解决交互的两个重要方面
饮酒的人的酒精和库维德。在特定目标1中,利用英国的数据
生物库,我们将询问饮酒或与酒精有关的疾病是否增加感染风险,
住院和死亡率。在特定目标2中,我们将使用单细胞RNA SEQ分析来询问影响
饮酒对外周先天和适应性免疫细胞中抗病毒反应的饮酒。理解
酒精使用对19009的风险的影响并表征抗病毒的特定细胞变化
回应将满足指导公共卫生和医疗反应的重要未满足的临床需求
2019冠状病毒病大流行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURA E. NAGY其他文献
LAURA E. NAGY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURA E. NAGY', 18)}}的其他基金
Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
- 批准号:
10207370 - 财政年份:2019
- 资助金额:
$ 16.09万 - 项目类别:
Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
- 批准号:
10430300 - 财政年份:2019
- 资助金额:
$ 16.09万 - 项目类别:
Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
- 批准号:
9765602 - 财政年份:2019
- 资助金额:
$ 16.09万 - 项目类别:
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair
AH 中的微生物代谢物和先天免疫:损伤和修复的生物标志物
- 批准号:
10428502 - 财政年份:2018
- 资助金额:
$ 16.09万 - 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
- 批准号:
10227144 - 财政年份:2018
- 资助金额:
$ 16.09万 - 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
- 批准号:
9753072 - 财政年份:2018
- 资助金额:
$ 16.09万 - 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
- 批准号:
10457954 - 财政年份:2018
- 资助金额:
$ 16.09万 - 项目类别:
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair
AH 中的微生物代谢物和先天免疫:损伤和修复的生物标志物
- 批准号:
9791131 - 财政年份:2018
- 资助金额:
$ 16.09万 - 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
- 批准号:
9977058 - 财政年份:2018
- 资助金额:
$ 16.09万 - 项目类别:
相似海外基金
Therapeutically harnessing anti-viral resident memory T cells in solid tumors
利用抗病毒驻留记忆 T 细胞治疗实体瘤
- 批准号:
10586695 - 财政年份:2023
- 资助金额:
$ 16.09万 - 项目类别:
Novel humanized mouse model of mucosal immunity
新型人源化小鼠粘膜免疫模型
- 批准号:
10591854 - 财政年份:2023
- 资助金额:
$ 16.09万 - 项目类别:
Differentiation of memory B cells requires EZH2 and epigenetic remodeling
记忆 B 细胞的分化需要 EZH2 和表观遗传重塑
- 批准号:
10680127 - 财政年份:2023
- 资助金额:
$ 16.09万 - 项目类别:
Structural Basis for T Cell Recognition of SARS-CoV-2
T 细胞识别 SARS-CoV-2 的结构基础
- 批准号:
10592711 - 财政年份:2023
- 资助金额:
$ 16.09万 - 项目类别:
CoVPN 3003 A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older LC 3
CoVPN 3003 评估 Ad26.COV2.S 在 18 岁及以上成年人中预防 SARS-CoV-2 介导的 COVID-19 的功效和安全性的 3 期研究 LC 3
- 批准号:
10570748 - 财政年份:2022
- 资助金额:
$ 16.09万 - 项目类别: